Pluri
Nimrod Bar Zvi has a comprehensive work experience, with a focus on the pharmaceutical industry. Nimrod is currently serving as the Chief Commercial Officer at Pluri Biotech, where they oversee the company's commercial activities related to cell-based technology platforms. Prior to this, they held the position of CEO at Pharmaserve, a pharmaceutical contract development and manufacturing organization specializing in respiratory products. Nimrod has also held various leadership roles at TAPI - Teva Active Pharmaceutical Ingredients, including Head of Sales for the US, Latam, and China regions, as well as Head of Sales for Europe and China. Nimrod has extensive experience in managing sales operations, business development, and strategic planning. Earlier in their career, Nimrod worked as a Sales and Marketing Manager at DHL Express, where they led a team in the special deliveries courier group.
Nimrod Bar Zvi's education history includes attending the Academic of Management and Alliance France Tel Aviv, but specific details such as start year, end year, degree name, and field of study are not provided.
Pluri
3 followers
Pluri is pushing the boundaries of science and engineering to create cell-based products for commercial use and is pioneering a biotech revolution that promotes global wellbeing and sustainability. The Company’s technology platform, a patented and validated state-of-the-art 3D cell expansion system, advances novel cell-based solutions for a range of initiatives— from medicine and climate change to food scarcity, animal cruelty and beyond. Pluri’s method is uniquely accurate, scalable, cost-effective, and consistent from batch to batch. Pluri currently operates in the field of regenerative medicine and food-tech and aims to establish partnerships that leverage the company’s 3D cell-based technology to additional industries that require effective, mass cell production. To learn more, visit us at www.pluri-biotech.com or follow us on LinkedIn and Twitter.